logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Showing 1 - 20 of 21 Items
Showing 1 - 20 of 21 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Poster

Diagnostic performance and feasibility of two new treatment decision algorithms for pulmonary tuberculosis in children: A diagnostic and mixed-methods multi-country study

Abdullah MB, Issa-Soumana A-M, Namulwana ML, Barry I, Fidelle Nyikayo L,  et al.
2024-05-03 • MSF Paediatric Days 2024
2024-05-03 • MSF Paediatric Days 2024
Journal Article
|
Research

Facteurs associés à la létalité chez les patients hospitalisés pour le VIH avancé

Abdourahimi D, Yehadji D, Briskin E, Khine EM, Arias C,  et al.
2023-08-01 • Public Health Action
2023-08-01 • Public Health Action
CONTEXTE
Une unité soutenue par Médecins Sans Frontières (MSF) qui prend en charge les patients avec un VIH avancé à l’Hôpital National de Donka, Conakry, Guinée.

OBJECTIF
Journal Article
|
Research

Poor outcomes among critically ill HIV-positive patients at hospital discharge and post-discharge in Guinea, Conakry: A retrospective cohort study

Albus SL, Harrison RE, Moudachirou R, Nanan-N’Zeth K, Haba B,  et al.
2023-03-13 • PLOS One
2023-03-13 • PLOS One
INTRODUCTION
Optimal management of critically ill HIV-positive patients during hospitalization and after discharge is not fully understood. This study describes patient characteristi...
Conference Material
|
Video

Spotlight on PMTCT for World Aids Day

Casas EDT
2022-12-01 • MSF Paediatric Days 2022
2022-12-01 • MSF Paediatric Days 2022
Journal Article
|
Review

Tuberculosis-HIV co-infection: progress and challenges after two decades of global antiretroviral treatment roll-out

Letang E, Ellis J, Naidoo K, Casas EDT, Sanchez P,  et al.
2020-07-01 • Archivos de Bronconeumologia
2020-07-01 • Archivos de Bronconeumologia
Despite wide antiretroviral scale-up during the past two decades resulting in declining new infections and mortality globally, HIV-associated tuberculosis remains as a major public healt...
Journal Article
|
Research

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A,  et al.
2020-03-20 • European Respiratory Journal
2020-03-20 • European Respiratory Journal
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a sta...
Journal Article
|
Research

Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needs

Ssonko C, Gonzalez L, Mesic A, da Fonseca M, Achar J,  et al.
2017-07-21 • Journal of the International AIDS Society
2017-07-21 • Journal of the International AIDS Society
INTRODUCTION
Countries in the West and Central African regions struggle to offer quality HIV care at scale, despite HIV prevalence being relatively low. In these challenging operatin...
Journal Article
|
Research

Acceptability of unsupervised peer-based distribution of HIV oral self-testing for the hard-to-reach in rural KwaZulu Natal, South Africa: results from a demonstration study

Kitenge M, Laxmeshwar C, Bermudez-Aza EH, Ford-Kamara E, van Custem G,  et al.
2022-03-30 • PLOS One
2022-03-30 • PLOS One
BACKGROUND
Innovative models to distribute oral HIV self-tests (HIVST) provide an opportunity to increase access to HIV testing, especially for hard-to-reach populations. This study ...
Protocol
|
Research Protocol

Evaluation of second line antiretroviral treatment outcomes and determinants in Epworth, MSF-OCA HIV cohort, Zimbabwe

Zizhou S, Gashu T, Ahmad B, Dhliwayo R, Aluma T,  et al.
2018-07-01
2018-07-01
Summary

Epworth poly-clinic is found in Epworth district, Harare. It is a clinic jointly run by Epworth local board (on behalf of the Ministry of Health and Child Care) and Mé...
Journal Article
|
Research

"Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis

Horter SCB, Stringer B, Reynolds L, Shoaib M, Kasozi S,  et al.
2014-02-21 • BMC Health Services Research
2014-02-21 • BMC Health Services Research
Ambulatory, community-based care for multi-drug resistant tuberculosis (MDR-TB) has been found to be effective in multiple settings with high cure rates. However, little is known about p...
Journal Article
|
Research

Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings

O'Brien DP, Spelman T, Greig J, McMahon J, Ssonko C,  et al.
2016-01-01 • Journal of the International AIDS Society
2016-01-01 • Journal of the International AIDS Society
INTRODUCTION
An increasing proportion of adult patients initiating antiretroviral therapy (ART) in resource-limited settings are aged >50 years. Older populations on ART appear to ha...
Journal Article
|
Research

Treatment Outcomes for HIV and MDR-TB Co-infected Adults and Children: Systematic Review and Meta-analysis

Isaakidis P, Casas EDT, Das M, Tseretopoulou X, Ford NP
2015-07-19 • International Journal of Tuberculosis and Lung Disease
2015-07-19 • International Journal of Tuberculosis and Lung Disease
The incidence of multidrug-resistant tuberculosis (MDR-TB) is increasing in high human immunodeficiency virus (HIV) prevalence settings, with high associated mortality. Treatment outcome...
Protocol
|
Research Protocol

Effectiveness and safety of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Manzini Region, Swaziland

Casas EDT
2014-07-01
2014-07-01
Multidrug resistant tuberculosis (MDR TB) is a growing problem and few people have access to adequate diagnosis and treatment. The current recommended treatment regimen for MDR TB has a ...
Journal Article
|
Research

Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in Eswatini (formerly Swaziland), 2011–2013

Verdecchia M, Keus K, Blankley S, Vambe D, Ssonko C,  et al.
2018-10-17 • PLOS One
2018-10-17 • PLOS One
INTRODUCTION
Since 2011 Médecins sans Frontières together with the eSwatini Ministry of Health have been managing patients with multi-drug resistant tuberculosis (MDR-TB) at Matsapha...
Journal Article
|
Research

Towards the WHO target of zero childhood tuberculosis deaths: an analysis of mortality in 13 locations in Africa and Asia

Russell GK, Merle CS, Cooke GS, Casas EDT, da Fonseca M,  et al.
2013-12-17 • International Journal of Tuberculosis and Lung Disease
2013-12-17 • International Journal of Tuberculosis and Lung Disease
SETTING
Achieving the World Health Organization (WHO) target of zero paediatric tuberculosis (TB) deaths will require an understanding of the underlying risk factors for mortality.
Journal Article
|
Commentary

New opportunities in tuberculosis prevention: implications for people living with HIV

Gonzalez Fernandez L, Casas EDT, Singh SN, Churchyard GJ, Brigden G,  et al.
2020-01-01 • Journal of the International AIDS Society
2020-01-01 • Journal of the International AIDS Society
INTRODUCTION:
Tuberculosis (TB) is a leading cause of mortality among people living with HIV (PLHIV). An invigorated global END TB Strategy seeks to increase efforts in scaling up T...
Journal Article
|
Research

Impact of HIV-Associated Conditions on Mortality in People Commencing Anti-Retroviral Therapy in Resource Limited Settings

Marshall C, Curtis A, Spelman T, O'Brien DP, Greig J,  et al.
2013-07-23 • PLOS One
2013-07-23 • PLOS One
To identify associations between specific WHO stage 3 and 4 conditions diagnosed after ART initiation and all cause mortality for patients in resource-limited settings (RLS). DESIGN, SET...
Journal Article
|
Research

Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs

Grimsrud A, Balkan S, Casas EDT, Lujan J, van Cutsem G,  et al.
2014-06-24 • Journal of Acquired Immune Deficiency Syndromes (1999)
2014-06-24 • Journal of Acquired Immune Deficiency Syndromes (1999)
Little is known about the evolution of program outcomes associated with rapid expansion of antiretroviral therapy (ART) in resource-limited settings. We describe temporal trends and asse...
Journal Article
|
Commentary

Getting HIV treatment to the most people

Lynch S, Ford NP, van Cutsem G, Bygrave H, Janssens B,  et al.
2012-07-20 • Science
2012-07-20 • Science
The new understanding that antiretroviral therapy (ART) can significantly reduce HIV transmission has stimulated scientific and political leaders to claim that ending the AIDS epidemic i...
Journal Article
|
Research

Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey

Conan N, Coulborn R M, Simons E, Mapfumo A, Apollo T,  et al.
2020-09-24 • Journal of the International AIDS Society
2020-09-24 • Journal of the International AIDS Society
Introduction: Gutu, a rural district in Zimbabwe, has been implementing comprehensive HIV care with the support of Médecins Sans Frontières (MSF) since 2011, decentralizing testing and t...